Jeff Ellsworth, based in Bedford, MA, US, is currently a Chief Scientific Officer at Recardia Therapeutics, Inc, bringing experience from previous roles at Stellar Research and Development LLC, Homology Medicines Inc., Stellar Research and Development, LLC and Avastus Preclinical Services LLC. Jeff Ellsworth holds a 1987 - 1988 Postdoctoral, Dept of Biological Sciences @ Stanford University. With a robust skill set that includes Aggregation, Gastrointestinal, Hepatology, Philadelphia, Gene Expression and more, Jeff Ellsworth contributes valuable insights to the industry. Jeff Ellsworth has 4 emails and 2 mobile phone numbers on RocketReach.